{
    "clinical_study": {
        "@rank": "115868", 
        "acronym": "QUARTO-II", 
        "brief_summary": {
            "textblock": "Optimization and evolution of the patient will be evaluated over 6 months after the implant."
        }, 
        "brief_title": "QUARTO-II Study to Evaluate the Management of Patients Resynchronized With the QuartetTM LV Quadripolar Lead", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Heart Failure", 
        "condition_browse": {
            "mesh_term": "Heart Failure"
        }, 
        "detailed_description": {
            "textblock": "Patient will be enrolled into the study after Informed Consent signature and\n      CRT-D+quadripolar (QuartetTM) LV lead."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient with implanted CRT-D device and a QuartetTM quadripolar lead by St. Jude\n             Medical in the left ventricle.\n\n          -  Patient with an echocardiographic study performed during 1 month prior to the implant\n             and in whom End Systolic Volume of the Left Ventricle (LVESV) has been measured\n\n          -  Patients who have granted their informed consent.\n\n          -  Patients above 18 years.\n\n        Exclusion Criteria:\n\n          -  Patients that have been previously resynchronized.\n\n          -  Patients with aortic stenosis or aortic valve prosthesis\n\n          -  Patients who are or may potentially be pregnant.\n\n          -  Patients with a life expectancy <12 months.\n\n          -  Patients who cannot attend the monitoring visits established by the protocol."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Heart failure patients"
            }
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 2, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01733368", 
            "org_study_id": "CR-1 2-015-SP-HF"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "CRT", 
            "Optimization", 
            "Responders"
        ], 
        "lastchanged_date": "November 20, 2012", 
        "number_of_groups": "1", 
        "official_title": "Observational Study to Evaluate the Management of Patients Resynchronized With the QuartetTM LV Quadripolar Lead", 
        "overall_contact": {
            "email": "ellorente@sjm.com", 
            "last_name": "Elena Llorente", 
            "phone": "+34917278940"
        }, 
        "overall_contact_backup": {
            "email": "aruiz@sjm.com", 
            "last_name": "Antonio Ruiz", 
            "phone": "+347278928"
        }, 
        "overall_official": {
            "affiliation": "Hospital Cl\u00ednico Universitario Virgen de la Victoria", 
            "last_name": "Javier Alzueta, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Spain: Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Optimization method. The primary endpoint of this study is to evaluate the usual management (according to the different methods of optimisation used) of patients undergoing Cardiac Resynchronization Therapy (CRT), that have a QuartetTM quadripolar lead with a CRT-D Device implanted during the 6 months post-implant.\nInformation about the optimization method used, parameters and variables used with them and number of optimization during 6months post-implant will be collected.", 
            "measure": "Optimization method", 
            "safety_issue": "No", 
            "time_frame": "From implant procedure until 6 months post-implant"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01733368"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Number of patients with device-related adverse events as a measure of safety, deaths, cardiovascular hospitalizations and hospitalisations for any reason, assessed up to 6 months post-implant.", 
                "measure": "Safety", 
                "safety_issue": "Yes", 
                "time_frame": "From implant procedure until 6 months post-implant"
            }, 
            {
                "description": "Structural remodelling is defined as a reduction >15% in End Systolic Volume of the Left Ventricle (LVESV), measured 6months after implant.", 
                "measure": "Percentage of responder patients (structural remodelling)", 
                "safety_issue": "No", 
                "time_frame": "6 Months after implant"
            }, 
            {
                "description": "Collect demographic information (gender, age, height, weight), medical and cardiovascular history.", 
                "measure": "Demographic data", 
                "safety_issue": "No", 
                "time_frame": "Up to 10 days post-implant"
            }, 
            {
                "description": "Number of treated TV/FV episodes over the 6 months post-implant", 
                "measure": "Treated TV/FV episodes incidence", 
                "safety_issue": "No", 
                "time_frame": "From implant procedure until 6 months post-implant"
            }
        ], 
        "source": "St. Jude Medical", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "St. Jude Medical", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "November 2012"
    }
}